Tc-99m depreotide scintigraphy of breast carcinoma

Clinical Nuclear Medicine

Volumn 27, Issue 3, 2002, Pages 202-204

  Montilla Soler, Jaime L ^a   Bridwell, Robert S ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

Breast Cancer; Depreotide; Nuclear Medicine; Scinitigraphy; Somatostatin; Technetium

Indexed keywords

DEPREOTIDE TC 99M; SOMATOSTATIN;

AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST ADENOCARCINOMA; BREAST BIOPSY; BREAST CARCINOMA; BREAST DISCHARGE; CANCER STAGING; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC VALUE; ERYTHEMA; FEMALE; HUMAN; MASTALGIA; MASTITIS; PREOPERATIVE EVALUATION; SCINTIMAMMOGRAPHY;

AGED; BREAST NEOPLASMS; FEMALE; HUMANS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; SOMATOSTATIN; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0036192411     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200203000-00011     Document Type: Article

References (8)

1. Somatostatin receptors in human endocrine tumors
2. Somatostatin receptor subtype specificity and in vivo binding of a novel tumor tracer, Tc99m-P829
3. Expression of Somatostatin receptor subtypes in breast carcinoma, carcinoid tumors and renal cell carcinoma
4. Antibody imaging in breast cancer
5. Breast cancer imaging with radiolabeled antibodies
6. Management of the axilla in conservatively treated breast cancer: 592 patients treated at Institut Gustave-Roussy
7. Conceptual and practical advances in the management of breast cancer
8. Treatment of curable carcinoma of the breast